| Issue |
Title |
File |
| Vol 11, No 2 (2014) |
A differentiated approach to the primary prevention of cardiovascular disease |
(Rus)
|
|
Napalkov D.A.
|
| Vol 13, No 4 (2016) |
A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension |
(Rus)
|
|
Ageev F.T., Smirnova M.D., Fofanova T.V., Blankova Z.N., Vitsenya M.V., Tsybulskaya T.V., Neverova E.F., Samsonova N.S.
|
| Vol 10, No 2 (2013) |
A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs |
|
|
Titov V.N.
|
| Vol 12, No 4 (2015) |
A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial |
(Rus)
|
|
Ostroumova O.D., Fomina V.M., Smolyarchuk E.A.
|
| Vol 14, No 2 (2017) |
A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment |
(Rus)
|
|
Temnikova E.A.
|
| Vol 15, No 4 (2018) |
Abdominal visceral adipose tissue ultrasound assessmet as a tool in predicting of high cardiometric risk obesity |
(Rus)
|
|
Druzhilov M.A., Druzhilova O.Y., Kuznetsova T.Y.
|
| Vol 14, No 2 (2017) |
Achievement of the main goals of therapy by using of a triple fixed combination of amlodipine, indapamide and perindopril (Co-Dalneva®) in patients with arterial hypertension |
(Rus)
|
|
Chukaeva I.I., Spiryakina Y.G., Glibko K.V., Orlov D.A., Bayramova A.S., Logunova I.Y.
|
| Vol 16, No 2 (2019) |
Acute heart failure and microRNA |
(Rus)
|
|
Nasonova S.N., Mindzaev D.R., Zhirov I.V., Tereshchenko S.N.
|
| Vol 10, No 2 (2013) |
Additional possibilities of antihypertensive therapy for metabolic syndrome |
|
|
Kislyak O.A., Pokhilchenko M.V.
|
| Vol 14, No 2 (2017) |
Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy? |
(Rus)
|
|
Martynyuk T.V., Chazova I.E.
|
| Vol 15, No 4 (2018) |
Advantages of control over the course of hypertension disease with the fixed combination of amlodipine and perindoprilе arginin |
(Rus)
|
|
Alyokhina O.D., Chesnokova I.V.
|
| Vol 16, No 3 (2019) |
Age-sex, ethnic and genetic peculiarities of high normal arterial blood pressure in residents of Mountain Shoria |
(Rus)
|
|
Mulerova T.A., Gruzdeva O.V., Maksimov V.N., Ogarkov M.I.
|
| Vol 8, No 3 (2011) |
Aktual'nye voprosy lecheniyaarterial'noy gipertenzii:fokus na kombinirovannuyu terapiyu |
|
|
Nebieridze D.V.
|
| Vol 11, No 1 (2014) |
Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass |
(Rus)
|
|
Yahontov D.A., Derisheva D.A., Gulyaeva L.F.
|
| Vol 6, No 2 (2009) |
Amlodipin in the treatment of arterial hypertension |
|
|
Galyavich A.S.
|
| Vol 6, No 4 (2009) |
Amlodipine: its ability to reduce the risk of complications of arterial hypertension |
|
|
Runikhina N.K., Tkacheva O.N.
|
| Vol 9, No 4 (2012) |
Analysis of antihypertensive therapy and its adherence in hypertensive patients with and without concomitant diabetes mellitus |
|
|
Sergeyeva V.A.
|
| Vol 9, No 4 (2012) |
Analysis of associations between genetic markers of erythrocytes of ав0, Rh, mn, P, kell blood group systems and arterial hypertension at the Altai Republic population |
|
|
Ogargov M.U., Mulerova T.A., Filimonov S.N., Luzina F.A., Onishchenko E.G.
|
| Vol 11, No 3 (2014) |
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan |
(Rus)
|
|
Trukhan D.I.
|
| Vol 14, No 1 (2017) |
Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application |
(Rus)
|
|
Maksimov M.L., Dralova O.V.
|
| Vol 6, No 3 (2009) |
Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan |
|
|
Vikulova O.K., Shestakova M.V.
|
| Vol 10, No 1 (2013) |
Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer |
|
|
Gilyarevsky S.R., Orlov V.A., Kuzmina I.M., Golshmid M.V.
|
| Vol 2, No 1 (2005) |
Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA) |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 8, No 1 (2011) |
Antagonisty retseptorov k angiotenzinu II v 2010 g.: chto novogo? |
|
|
Ostroumova O.D., Maksimov M.L., Shchukina G.N., Shorikova E.G.
|
| Vol 5, No 4 (2008) |
Antigipertenzivnaya effektivnost' antagonistov kal'tsiya u bol'nykhs arterial'noy gipertoniey v zavisimosti ot riskaserdechno-sosudistykh oslozhneniy |
|
|
Chazova I.E., Ratova L.G., Galyavich A.S., Gapon L.I., Ivashkin V.T., Katel'nitskaya L.I., Martsevich S.Y., Nedogoda S.V.
|
| Vol 8, No 4 (2011) |
Antigipertenzivnaya effektivnost' irbesartana |
|
|
Ostroumova O.D., Shchukina G.N., Fomina V.M.
|
| Vol 5, No 2 (2008) |
Antigipertenzivnaya effektivnost' moksonidina u patsientov s ozhireniem i nekontroliruemoy arterial'noy gipertenziey |
|
|
Jose Abellan -., Mariano Leal -., Fernando Hernandez-Menarguez -., Jose A.G., Antonio Martinez-Pastor -., Soledad Garcia de Vinuesa -., Jose Luno -.
|
| Vol 1, No 1 (2004) |
Antigipertenzivnaya effektivnost' valsartana, vliyanie na sostoyanie tsentral'noy gemodinamiki i mikrotsirkulyatsii: vzglyad s pozitsiy organoprotektsii |
|
|
Podzolkov V.I., Bulatov V.A., Son E.A., Makolkin V.I.
|
| Vol 7, No 4 (2010) |
Antigipertenzivnaya i kardioprotektivnaya effektivnost' lozartana u bol'nykh arterial'noy gipertenziey s gipertrofiey miokarda levogo zheludochka:rezul'taty dlitel'nogo (6-12 mes) nablyudeniya v usloviyakh poliklinicheskoy praktiki |
|
|
Chikhladze N.M., Sakhnova T.A., Blinova E.V., Yarovaya E.B., Chazova I.E.
|
| Vol 4, No 1 (2007) |
Antigipertenzivnaya terapiya vo vtorichnoy profilaktike |
|
|
Parfenov V.A., Starchina Y.A.
|
| Vol 7, No 2 (2010) |
Antigipertenzivnaya terapiya vo vtorichnoy profilaktike insul'ta i postinsul'tnoy dementsii |
|
|
Ostroumova O.D., Stepura O.B., Bondarets O.V., Guseva T.F.
|
| Vol 4, No 2 (2007) |
Antigipertenzivnaya terapiya: mesto nefiksirovannykh kombinatsiy preparatov |
|
|
Ratova L.G., Chazova I.E.
|
| Vol 10, No 1 (2013) |
Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension |
|
|
Glukhova T.V., Solgalova S.A., Alferov V.V.
|
| Vol 13, No 3 (2016) |
Application of advanced electrovectorcardiographic methods in the diagnosis of left ventricular hypertrophy on the basis of Uryupinsk central district hospital |
(Rus)
|
|
Vishnyakova N.A., Ryabykina G.V., Sakhnova T.A., Blinova E.V., Kozhemiakina E.S., Volkov V.E.
|
| Vol 11, No 4 (2014) |
Arterial hypertension and brain damage. New targets of therapy |
(Rus)
|
|
Yanishevskiy S.N., Mirnaya D.A., Andreyev R.V.
|
| Vol 6, No 2 (2009) |
Arterial hypertension and sleep apnea in pediatrics: results of pilot trial |
|
|
Madaeva I.M., Shevyrtalova O.N., Dolgikh V.V., Madaeva I.M., Shevyrtalova O.N., Dolgich V.V.
|
| Vol 6, No 1 (2009) |
Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin |
|
|
Ezhov M.V., Yezhov M.V.
|
| Vol 15, No 2 (2018) |
Arterial hypertension in patients with non-specific aortoarteritis |
(Rus)
|
|
Chikhladze N.M.
|
| Vol 6, No 4 (2009) |
Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia. |
|
|
Ostroumova O.D., Korsakova N.K., Varako N.A.
|
| Vol 14, No 1 (2017) |
Arterial hypertension treatment changes in Yaroslavl region: results obtained after 4 years of complex program of regional healthcare system’s improvement implementation |
(Rus)
|
|
Mozheyko M.E., Vigdorchik A.V., Eregin S.Y., Danilenko N.V., Klimovskaya I.M., Ramanathan K., Hughes D.
|
| Vol 5, No 2 (2008) |
Arterial'naya gipertenziya i faktory serdechno-sosudistogo riska. Vozmozhnost' upravleniya situatsiey |
|
|
Volkova E.G.
|
| Vol 9, No 3 (2012) |
Arterial'naya gipertenziya pri ostrom insul'te - drug ili vrag? (Lektsiya) |
|
|
Tsarenko S.V.
|
| Vol 5, No 4 (2008) |
Arterial'naya gipertenziya u beremennykh |
|
|
Tkacheva O.N., Runikhina N.K., Mishina I.E., Barabashkina A.V.
|
| Vol 10, No 3 (2013) |
Arterial'naya gipertenziya u zhenshchin v postmenopauze: interv'yu s ekspertom |
|
|
Tkacheva O.N.
|
| Vol 7, No 1 (2010) |
Arterial'naya gipertenziya: znachenie individual'nogo vybora lekarstvennykh sredstv i mesto β-adrenoblokatorov |
|
|
Morozova T.E.
|
| Vol 9, No 1 (2012) |
Arterial'naya gipertoniya i bronkhoobstruktivnaya patologiya - osobennosti klinicheskoy kartiny |
|
|
Ratova L.G., Zykov K.A., Dolgusheva Y.A., Agapova O.Y., Nazarov B.M., Chazova I.E.
|
| Vol 1, No 1 (2004) |
Arterial'naya gipertoniya i ishemicheskaya bolezn' serdtsa: poisk optimal'nykh podkhodov k lecheniyu (po rezul'tatam issledovaniya INVEST) |
|
|
Chazova I.E.
|
| Vol 4, No 2 (2007) |
Arterial'naya gipertoniya i postmenopauza: vozmozhnosti ingibitora angiotenzinprevrashchayushchego fermenta enalaprila |
|
|
Morozova T.E., Syumakova S.A.
|
| Vol 2, No 2 (2005) |
Arterial'naya gipertoniya i tserebrovaskulyarnye narusheniya |
|
|
Skvortsova V.I.
|
| Vol 5, No 2 (2008) |
Arterial'naya gipertoniya, kurenie, pochki - chto obshchego? Rezul'taty issledovaniya IRIS |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 5, No 1 (2008) |
Arterial'naya gipertoniya pri zabolevaniyakh shchitovidnoy zhelezy |
|
|
Mychka V.B., Chazova I.E.
|
| Vol 4, No 1 (2007) |
Arterial'naya gipertoniya – mishen' dlya pervichnoy profilaktiki serdechno-sosudistykh zabolevaniy, obuslovlennykh aterosklerozom: est' li neobkhodimost' primenyat' statiny? |
|
|
Mamedov M.N.
|
| Vol 5, No 3 (2008) |
Arterial'naya gipotenziya kak faktor riska smertnosti |
|
|
Tyurina T.V.
|
| Vol 5, No 3 (2008) |
Arterial'naya gipotoniya u bol'nykh s vtorichnym giperal'dosteronizmom: sindromy Barttera i Gitel'mana |
|
|
Chikhladze N.M.
|
| Vol 18, No 1 (2021) |
Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II |
(Rus)
|
|
Chazova I.E., Martynyuk T.V., Rodnenkov O.V., Gorieva S.B., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galyavich A.S., Rotar’ O.P., Khaisheva L.A., Kameneva T.R.
|
| Vol 13, No 2 (2016) |
Assessment of efficiency and safety of application of the reproduced drug of Mertenil® according to MSCT-coronary angiography |
(Rus)
|
|
Malov A.A., Feiskhanova L.I.
|
| Vol 17, No 4 (2020) |
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity |
(Rus)
|
|
Blinova N.V., Azimova M.O., Zhernakova J.V., Saidova M.A., Ternovoy S.K., Zheleznova E.A., Azimova M.R., Chazova I.Е.
|
| Vol 12, No 4 (2015) |
Association of clinical and genetic factors with left ventricular hypertrophy in hypertension among the indigenous population Mountain Shoria |
(Rus)
|
|
Mulerova T.A., Kuzmina A.A., Chigisova A.N., Voropaeva E.N., Maksimov V.N., Voevoda M.I., Ogarkov M.Y.
|
| Vol 6, No 3 (2009) |
Atherosclerotic stenos of renal arteries at patients with diabetes mellitus and arterial hypertension. |
|
|
Fomin V.V., Moiseev S.V., Shvetsov M.Y., Mukhin N.A.
|
| Vol 12, No 2 (2015) |
Autoregulation hemodynamics in pregnancies complicated by hypertensive disorders |
(Rus)
|
|
Makarov R.A., Kinzhalova S.V., Davydova N.S.
|
| Vol 9, No 4 (2012) |
B-ADRENOBLOCKERS IN THERAPY FOR ARTERIAL HYPERTENSION: ON THE WAY TO REASONABLE COMPROMISE |
|
|
Perepech N.B., Shurygina V.D.
|
| Vol 5, No 3 (2008) |
b-Adrenoblokator s unikal'nymi kharakteristikami - nebivolol |
|
|
Ratova L.G., Chazova I.E.
|
| Vol 8, No 2 (2011) |
b-Adrenoblokatory vchera, segodnyai zavtra: smogut li oni ostat'syav gruppe osnovnykh lekarstvennykhsredstv? |
|
|
Fomin I.V., Polyakov D.S.
|
| Vol 14, No 1 (2017) |
Balloon angioplasty as an alternative to thromboendarterectomy for proximal pulmonary artery obstruction in a patient with chronic thromboembolic pulmonary hypertension: a case report |
(Rus)
|
|
Danilov N.M., Matchin Y.G., Iarovoi S.Y., Demchenkova A.Y., Chazova I.E.
|
| Vol 11, No 3 (2014) |
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol |
(Rus)
|
|
Baryshnikov G.A., Stepanova I.I., Kudryavtseva N.A.
|
| Vol 14, No 3 (2017) |
Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease |
(Rus)
|
|
Fomin I.V., Polyakov D.S.
|
| Vol 5, No 1 (2008) |
Beta-blokatory v lechenii arterial'noy gipertonii,ili Velikobritaniya protiv ostal'noy Evropy |
|
|
Tereshchenko S.N., Zhirov I.V.
|
| Vol 7, No 4 (2010) |
Blokator retseptorov k angiotenzinu II v obespechenii arterial'noy normotenzii, adaptivnosti i komplaentnosti u patsientov s gipertonicheskoy bolezn'yu. |
|
|
Kompaniets O.G., Pokrovskiy V.M.
|
| Vol 3, No 1 (2006) |
Blokatory beta-adrenergicheskikh retseptorov v lechenii arterial'noy gipertenzii u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu |
|
|
Preobrazhenskiy D.V., Tarykina E.V., Sidorenko B.A., Ermakova T.A., Stetsenko T.M., Pataraya S.A.
|
| Vol 10, No 3 (2013) |
Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii |
|
|
Shilov A.M.
|
| Vol 5, No 1 (2008) |
Blokatory retseptorov angiotenzina II pokazany bol'shinstvu bol'nykh arterial'noy gipertenziey? |
|
|
Fomin V.V.
|
| Vol 2, No 2 (2005) |
Blokatory retseptorov angiotenzina II pri lechenii arterial'noy gipertonii |
|
|
Ol'binskaya L.I.
|
| Vol 3, No 1 (2006) |
Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny |
|
|
Shestakova M.V.
|
| Vol 2, No 2 (2005) |
Blokatory retseptorov k angiotenzinu II – osoznannyy vybor patsienta |
|
|
Chazova I.E., Ratova L.G., Kolos I.P.
|
| Vol 15, No 2 (2018) |
Blood pressure level and arterial stiffness parameters role in prediction of the antihypertensive therapy efficacy escape phenomenon |
(Rus)
|
|
Mikhailova O.O., Elfimova E.M., Litvin A.Y., Rogoza A.N.
|
| Vol 18, No 4 (2021) |
Blood pressure variability, endothelial dysfunction, and C-reactive protein levels in arterial hypertension in combination with coronary artery disease |
(Rus)
|
|
Musikhina N.A., Petelina T.I., Gapon L.I., Kostousova A.I.
|
| Vol 14, No 3 (2017) |
Calcineurin inhibitors and arterial hypertension in recipients of solid organs |
(Rus)
|
|
Kosmacheva E.D., Martirosyan S.M., Lepshokova M.K., Babich A.E.
|
| Vol 13, No 2 (2016) |
Calcium antagonists in pharmacotherapy in patients with concomitant cardiac pathology: priorities of the recommendations in clinical practice |
(Rus)
|
|
Kompaniets O.G., Linchak R.M., Ketova G.G.
|
| Vol 12, No 2 (2015) |
Calcium channel blockers: more than 50 years on guard of health |
(Rus)
|
|
Chazova I.E., Zhernakova Y.V.
|
| Vol 6, No 4 (2009) |
Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke |
|
|
Drapkina O.M., Dikur O.N.
|
| Vol 11, No 1 (2014) |
Candesartan in treating hypertension |
(Rus)
|
|
Minushkina L.O.
|
| Vol 12, No 2 (2015) |
Cardioncology: management of arterial hypertension in patients with cancer on chemotherapy |
(Rus)
|
|
Chazova I.E., Oschepkova E.V., Kirillova M.Y., Sharipova G.C.
|
| Vol 14, No 1 (2017) |
Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study) |
(Rus)
|
|
Efremova Y.E., Oshchepkova E.V., Zhernakova Y.V., Chazova I.E., Iarovaia E.B., Shalnova S.A., Rotar O.P., Konradi A.O., Shliakhto E.V., Boitsov S.A.
|
| Vol 12, No 1 (2015) |
Central and humoral mechanisms for arterial hypertension in women |
(Rus)
|
|
Podzolkov V.I., Bragina A.E., Rodionova J.N., Koloda J.A.
|
| Vol 5, No 2 (2008) |
Chem luchshe osushchestvit' blokadu renin-angiotenzin-al'dosteronovoy sistemy |
|
|
Drapkina O.M.
|
| Vol 14, No 1 (2017) |
Chronic kidney disease and cardiovascular events: a focus on central blood pressure |
(Rus)
|
|
Murkamilov I.T., Aitbaev K.A., Sabirov I.S., Fomin V.V., Yusupov F.A.
|
| Vol 15, No 4 (2018) |
Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case |
(Rus)
|
|
Bykov A.N., Arkhipov M.V., Klimusheva N.F., Iofin A.I., Krokhalev V.Y.
|
| Vol 11, No 2 (2014) |
Chronic obstructive pulmonary disease combined with arterial hypertension: efficacy and safety ofthesustained-release indapamide (Arifon® retard) |
(Rus)
|
|
Ovcharenko S.I., Nersesyan Z.N., Morozova T.E.
|
| Vol 13, No 2 (2016) |
Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure |
(Rus)
|
|
Aksenova A.V., Elfimova E.M., Litvin A.Y., Chazova I.E.
|
| Vol 1, No 1 (2004) |
Chto lezhit v osnove effektivnosti lecheniya perindoprilom bol'nykh ishemicheskoy bolezn'yu serdtsa – nebol'shoe snizhenie arterial'nogo davleniya ili nechto bol'shee? Itogi i perspektivy issledovaniya EUROPA |
|
|
Khirmanov V.N.
|
| Vol 18, No 1 (2021) |
Clinical and functional characteristics of arterial stiffness in elderly |
(Rus)
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Z.A., Redzhapova N.A., Yusupov F.A.
|
| Vol 14, No 3 (2017) |
Clinical and genetic factors determining target lesions of patients with arterial hypertension among Mountain Shoria population |
(Rus)
|
|
Mulerova T.A.
|
| Vol 12, No 2 (2015) |
Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension |
(Rus)
|
|
Zavyrylina I.N., Arkhipova O.A., Saidova M.A., Danylov N.M., Martynyuk T.V., Chazova I.E.
|
| Vol 6, No 1 (2009) |
Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension |
|
|
Ivanov K.P., Mychka V.B., Kirillova M.Y., Chazova I.E., Ivanov K.P., Mychka V.B., Kirillov M.J., Chazova I.E.
|
| Vol 12, No 4 (2015) |
Clinical effects of one-year physical training program in arterial hypertension patients of working age who have suffered acute myocardial infarction (Russian randomized controlled trial) |
(Rus)
|
|
Aronov D.M., Bubnova M.G., Krasnitskiy V.B., Ioseliani D.G., Grinshteyn Y.I., Gulyaeva S.F., Efremushkin G.G., Lyamina N.P.
|
| Vol 14, No 2 (2017) |
Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up |
(Rus)
|
|
Gapon L.I., Mikova E.V., Savelyeva N.Y., Kolunin G.V., Zherzhova A.Y.
|
| Vol 18, No 3 (2021) |
Clinical features and course of arterial hypertension in patients with its various forms |
(Rus)
|
|
Denisova A.R., Esaulova T.E., Solntseva T.D., Sivakova O.A., Chazova I.E.
|
| Vol 16, No 3 (2019) |
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice |
(Rus)
|
|
Gratsianskaya S.E., Valieva Z.S., Zorin A.V., Martynyuk T.V.
|
| Vol 17, No 2 (2020) |
Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents |
(Rus)
|
|
Aleksandrov A.A., Kisliak O.A., Leontyeva I.V.
|
| Vol 14, No 3 (2017) |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I |
(Rus)
|
|
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Ovchinnikov A.G., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T.
|
| 1 - 100 of 734 Items |
1 2 3 4 5 6 7 8 > >> |
